NUVB
Price
$3.20
Change
+$0.19 (+6.31%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.03B
40 days until earnings call
XNCR
Price
$11.57
Change
+$1.24 (+12.00%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
736.77M
45 days until earnings call
Interact to see
Advertisement

NUVB vs XNCR

Header iconNUVB vs XNCR Comparison
Open Charts NUVB vs XNCRBanner chart's image
Nuvation Bio
Price$3.20
Change+$0.19 (+6.31%)
Volume$24.77K
Capitalization1.03B
Xencor
Price$11.57
Change+$1.24 (+12.00%)
Volume$34.15K
Capitalization736.77M
NUVB vs XNCR Comparison Chart in %
Loading...
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NUVB vs. XNCR commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVB is a Buy and XNCR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (NUVB: $3.20 vs. XNCR: $11.57)
Brand notoriety: NUVB and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NUVB: 42% vs. XNCR: 60%
Market capitalization -- NUVB: $1.03B vs. XNCR: $736.77M
NUVB [@Biotechnology] is valued at $1.03B. XNCR’s [@Biotechnology] market capitalization is $736.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUVB’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • NUVB’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both NUVB and XNCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVB’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 6 bullish TA indicator(s).

  • NUVB’s TA Score: 5 bullish, 4 bearish.
  • XNCR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than NUVB.

Price Growth

NUVB (@Biotechnology) experienced а -0.62% price change this week, while XNCR (@Biotechnology) price change was +12.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

NUVB is expected to report earnings on Nov 05, 2025.

XNCR is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($1.03B) has a higher market cap than XNCR($737M). NUVB YTD gains are higher at: 20.301 vs. XNCR (-49.652). XNCR has higher annual earnings (EBITDA): -125.38M vs. NUVB (-201.17M). NUVB has more cash in the bank: 608M vs. XNCR (444M). NUVB has less debt than XNCR: NUVB (57.8M) vs XNCR (67.9M). XNCR has higher revenues than NUVB: XNCR (147M) vs NUVB (14.4M).
NUVBXNCRNUVB / XNCR
Capitalization1.03B737M140%
EBITDA-201.17M-125.38M160%
Gain YTD20.301-49.652-41%
P/E RatioN/AN/A-
Revenue14.4M147M10%
Total Cash608M444M137%
Total Debt57.8M67.9M85%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NUVBXNCR
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 5 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 18 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
NUVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GBCAX18.78N/A
N/A
Gabelli Dividend Growth A
TRDIX8.47N/A
N/A
Transamerica Sustainable Equity Inc I2
VPRAX26.57N/A
N/A
VY® T. Rowe Price Capital Apprec R6
IIVAX27.51N/A
N/A
Transamerica Small/Mid Cap Value A
TEMSX9.94N/A
N/A
Nuveen Emerging Markets Eq Retiremt

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
+6.31%
BEAM - NUVB
48%
Loosely correlated
-0.48%
DNLI - NUVB
47%
Loosely correlated
+3.87%
RCUS - NUVB
46%
Loosely correlated
+3.88%
XNCR - NUVB
45%
Loosely correlated
+12.00%
OCUL - NUVB
44%
Loosely correlated
+2.33%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with CRNX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+12.00%
CRNX - XNCR
62%
Loosely correlated
+27.92%
DYN - XNCR
58%
Loosely correlated
+4.53%
SYRE - XNCR
56%
Loosely correlated
+4.04%
CGON - XNCR
56%
Loosely correlated
+3.02%
NUVL - XNCR
56%
Loosely correlated
+4.99%
More